Sarcoma trials, also abroad
605 open Sarcoma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC) has 2 sites in Hong Kong and runs in 21 countries. If a site near you is full, another one may still take people.
See A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC) in all 21 countries